Why the study?
The 2025 ESC guidelines for managing cardiovascular disease and pregnancy require contextualization and additional recommendations to align with Dutch clinical practice.
This document provides the official Dutch adaptation of the 2025 ESC guidelines on cardiovascular disease and pregnancy, highlighting the importance of multidisciplinary care and aligning recommendations with local protocols.
Provides Dutch clinicians with adapted recommendations for cardiovascular disease in pregnancy; extends 2025 ESC guidelines to align with national protocols.
This article contextualises the 2025 European Society of Cardiology (ESC) guidelines for managing cardiovascular disease (CVD) and pregnancy in the Netherlands. The guideline addendum provides additional recommendations for situations where the ESC guidelines may not fully align with Dutch clinical practice. By endorsing the ESC guidelines through this addendum, the Netherlands Society of Cardiology (Nederlandse Vereniging Voor Cardiologie) supports its members in adhering to evidence-based management strategies for CVD and pregnancy.
No takes yet. Share an insight, caveat, or question.
Zwaan et al. (2026) conducted a review in Cardiovascular disease in pregnancy. 2025 ESC Guidelines on cardiovascular disease and pregnancy (Dutch addendum) was evaluated. The Netherlands Society of Cardiology endorsed the 2025 ESC guidelines for managing cardiovascular disease and pregnancy while providing specific modifications to align with Dutch clinical practice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: